Grifols seals financing for Talecris deal

* Signs $3.4 billion loan for Talecris

* To launch $1.1 billion in bonds in coming weeks

* Shares up 2.9 percent

MADRID, Nov 24 (BestGrowthStock) – Spain’s Grifols (GRLS.MC: ) has
signed a $3.4 billion financing agreement to buy U.S. peer
Talecris Biotherapeutics (TLCR.O: ) in a bid to become the world’s
third-largest maker of haemoderivative products.

Grifols will also launch a $1.1 billion bond issue in the
coming weeks to cover the maximum cost of the takeover,
estimated at $4.5 billion, the company said in a statement on

The deal still needs to be approved by the U.S. Federal
Trade Commission.

Grifols shares were up 2.9 percent at 9.63 euros by 1022
GMT, outpacing a 0.3 percent decline on Spain’s blue-chip index
(.IBEX: ).
(Reporting by Tracy Rucinski; Editing by Will Waterman)

Grifols seals financing for Talecris deal